Clinical Trial Update: A Study of JNJ-75348780 in Participants With Non-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL) [Phase 1]

View source ↗

Summary

This clinical trial update reports the Phase 1 study of JNJ-75348780 in participants with Non-Hodgkin lymphoma and chronic lymphocytic leukemia, which has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Non-hodgkin Lymphoma

Drugs mentioned

• JNJ-75348780

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell | Phase 1 | Status: COMPLETED